X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-10 | CLNN | Matlin David J | Dir | P - Purchase | $0.41 | +250,002 | 7,193,686 | +4% | +$102,501 | ||||||
D | 2023-06-16 | CLNN | Ugwumba Chidozie | Resigned as director 2/15/2023, 10% | P - Purchase | $0.80 | +7,500,000 | 13,018,908 | +136% | +$6,000,000 | |||||
2023-06-26 | CLNN | Stevens John Henry | Dir | P - Purchase | $0.80 | +316,455 | 908,857 | +53% | +$253,164 | ||||||
2023-06-26 | CLNN | Etherington Robert Dee | CEO | P - Purchase | $0.81 | +25,000 | 94,310 | +36% | +$20,250 | ||||||
D | 2023-06-16 | CLNN | Mosca Alison | Dir | P - Purchase | $0.80 | +2,394,375 | 7,744,466 | +45% | +$1,915,500 | |||||
D | 2023-06-16 | CLNN | Gay Jonathon | Dir | P - Purchase | $0.80 | +105,625 | 2,329,218 | +5% | +$84,500 | |||||
D | 2023-06-16 | CLNN | Matlin David J | Dir | P - Purchase | $0.80 | +1,500,000 | 6,943,684 | +28% | +$1,200,000 | |||||
2022-11-02 | CLNN | Matlin David J | Dir | P - Purchase | $1.01 | +2,871,287 | 5,443,684 | +112% | +$2,900,000 | ||||||
2022-11-02 | CLNN | Gay Jonathon | Dir | P - Purchase | $1.01 | +990,099 | 2,223,593 | +80% | +$1,000,000 | ||||||
2022-11-02 | CLNN | Ugwumba Chidozie | Dir | P - Purchase | $1.01 | +990,099 | 5,518,908 | +22% | +$1,000,000 | ||||||
2022-11-02 | CLNN | Mosca Alison | Dir | P - Purchase | $1.01 | +792,079 | 5,350,091 | +17% | +$800,000 | ||||||
2022-11-02 | CLNN | Stevens John Henry | Dir | P - Purchase | $1.01 | +148,515 | 592,402 | +33% | +$150,000 | ||||||
2022-08-17 | CLNN | Stevens John Henry | Dir | P - Purchase | $3.85 | +47,662 | 443,887 | +12% | +$183,499 | ||||||
2022-07-18 | CLNN | Etherington Robert Dee | CEO | S - Sale | $4.72 | -23,483 | 69,310 | -25% | -$110,840 | ||||||
M | 2022-06-16 | CLNN | Matlin David J | Dir | P - Purchase | $2.50 | +149,610 | 2,572,397 | +6% | +$374,771 | |||||
2022-06-16 | CLNN | Mortenson Mark | Chief Science Officer | S - Sale | $2.47 | -20,247 | 168,759 | -11% | -$50,010 | ||||||
2022-06-15 | CLNN | Mosca Alison | Dir | P - Purchase | $2.62 | +5,000 | 4,558,012 | 0% | +$13,100 | ||||||
M | 2022-06-14 | CLNN | Matlin David J | Dir | P - Purchase | $2.66 | +96,011 | 2,422,787 | +4% | +$255,389 | |||||
2022-06-13 | CLNN | Matlin David J | Dir | P - Purchase | $3.06 | +55,000 | 2,326,776 | +2% | +$168,300 | ||||||
M | 2022-06-03 | CLNN | Matlin David J | Dir | P - Purchase | $2.55 | +60,670 | 2,271,776 | +3% | +$154,822 | |||||
2022-05-27 | CLNN | Matlin David J | Dir | P - Purchase | $2.27 | +35,000 | 2,211,106 | +2% | +$79,450 | ||||||
2022-05-16 | CLNN | General Resonance LLC | 10% | S - Sale | $2.20 | -181,818 | 15,560,212 | -1% | -$400,000 | ||||||
2022-05-16 | CLNN | Matlin David J | Dir | P - Purchase | $2.20 | +181,818 | 2,176,106 | +9% | +$400,000 | ||||||
2022-05-16 | CLNN | Glanzman Robert | Chief Medical Officer | S - Sale | $2.03 | -4,717 | 10,564 | -31% | -$9,576 | ||||||
2022-05-16 | CLNN | Gay Jonathon | Dir | P - Purchase | $2.08 | +10,000 | 1,233,494 | +1% | +$20,800 | ||||||
2022-04-21 | CLNN | General Resonance LLC | 10% | S - Sale | $3.01 | -132,891 | 15,742,030 | -1% | -$400,002 | ||||||
2022-04-20 | CLNN | Matlin David J | Dir | P - Purchase | $3.01 | +132,891 | 1,994,288 | +7% | +$400,002 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |